Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Division of Pediatric Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA.
Cartilage. 2020 Jan;11(1):9-18. doi: 10.1177/1947603518783503. Epub 2018 Jul 2.
To perform a systematic review of clinical outcomes following microfracture (MFX), autologous chondrocyte implantation (ACI), osteochondral allograft transplantation (OCA), and osteochondral autograft transplantation system (OATS) to treat articular cartilage lesions in pediatric and adolescent patients. We sought to compare postoperative improvements for each cartilage repair method to minimal clinically important difference (MCID) thresholds.
MEDLINE, Web of Science, Scopus, and Cochrane Library databases were searched for studies reporting MCID-validated outcome scores in a minimum of 5 patients ≤19 years treated for symptomatic knee chondral lesions with minimum 1-year follow-up. One-sample tests were used to compare mean outcome score improvements to established MCID thresholds.
Twelve studies reporting clinical outcomes on a total of 330 patients following cartilage repair were identified. The mean age of patients ranged from 13.7 to 16.7 years and the mean follow-up was 2.2 to 9.6 years. Six studies reported on ACI, 4 studies reported on MFX, 2 studies reported on OATS, and 1 study reported on OCA. ACI ( < 0.001, = 0.008) and OCA ( < 0.001) showed significant improvement for International Knee Documentation Committee (IKDC) scores with regard to MCID while MFX ( = 0.66) and OATS ( = 0.11) did not. ACI ( < 0.001) and OATS ( = 0.010) both showed significant improvement above MCID thresholds for Lysholm scores. MFX ( = 0.002) showed visual analog scale (VAS) pain score improvement above MCID threshold while ACI ( = 0.037, = 0.070) was equivocal.
Outcomes data on cartilage repair in the pediatric and adolescent knee are limited. This review demonstrates that all available procedures provide postoperative improvement above published MCID thresholds for at least one reported clinical pain or functional outcome score.
系统评价微骨折术(MFX)、自体软骨细胞移植术(ACI)、骨软骨同种异体移植术(OCA)和骨软骨自体移植系统(OATS)治疗儿童和青少年膝关节软骨病变的临床疗效。我们旨在比较每种软骨修复方法术后改善情况与最小临床重要差异(MCID)阈值的关系。
在 MEDLINE、Web of Science、Scopus 和 Cochrane 图书馆数据库中检索了至少有 5 名≤19 岁的症状性膝关节软骨病变患者接受 MCID 验证的疗效评分,并进行了至少 1 年随访的研究。采用单样本 t 检验比较了平均疗效评分改善与既定 MCID 阈值的关系。
共纳入 12 项研究,涉及 330 例接受软骨修复的患者,报道了临床结果。患者的平均年龄为 13.7 至 16.7 岁,平均随访时间为 2.2 至 9.6 年。6 项研究报道了 ACI,4 项研究报道了 MFX,2 项研究报道了 OATS,1 项研究报道了 OCA。ACI(<0.001,=0.008)和 OCA(<0.001)在国际膝关节文献委员会(IKDC)评分方面显示出显著的 MCID 改善,而 MFX(=0.66)和 OATS(=0.11)则没有。ACI(<0.001)和 OATS(=0.010)在 Lysholm 评分方面均显示出显著高于 MCID 阈值的改善。MFX(=0.002)在视觉模拟量表(VAS)疼痛评分方面显示出高于 MCID 阈值的改善,而 ACI(=0.037,=0.070)则存在争议。
儿童和青少年膝关节软骨修复的疗效数据有限。本综述表明,所有可用的手术方法在至少一种报告的临床疼痛或功能结果评分方面,术后改善均高于已发表的 MCID 阈值。